Sentien Biotechnologies, Inc.

📍 United States👥 10 employees💰 Last funded 2017
Biotechnology🌐 sentienbiotech.com
Website LinkedIn
Sentien’s mission is to harness the power of cell therapy with innovative drug delivery systems to treat a wide range of acute inflammatory diseases. Our lead product is designed to allow for controlled, sustained delivery of mesenchymal stem cell (MSC) secreted factors. This approach immobilizes the MSCs in an extracorporeal device, allowing for doses of therapeutic secreted factors that are unattainable by direct injection.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sentien Biotechnologies, Inc.?
Sentien Biotechnologies, Inc. has 1 investors on record on gritt.io.
When did Sentien Biotechnologies, Inc. last raise funding?
The most recent investment in Sentien Biotechnologies, Inc. recorded on gritt.io was in 2017.
What industry is Sentien Biotechnologies, Inc. in?
Sentien Biotechnologies, Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Sentien Biotechnologies, Inc. based?
Sentien Biotechnologies, Inc. is headquartered in United States.